Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Use of statins rising among very elderly

Between 1999 and 2012, the use of cholesterol-lowering statin drugs increased among people over age 79 with no history of coronary heart disease, stroke or vascular disease, according to a new study. People who have had a heart attack, stroke or diabetes are often prescribed a statin like atorvastatin (Lipitor) to reduce their risk of […]

Read More »

Dental device promises pain-free tooth repair

A filling is one of the most common procedures carried out by dentists. But just the thought of anesthetic injections followed by the sound of the drill is enough to send shivers down the spine of many people. But a new technology developed by British scientists could dramatically reduce the need for unpleasant dental drilling. […]

Read More »

Physicians and Patients Need Comparative Effectiveness Studies That Target Specific Treatment Pathways, According to Cutting Edge Information

RESEARCH TRIANGLE PARK, NC–(Marketwired – August 25, 2015) – New research from pharmaceutical intelligence firm Cutting Edge Information shows that patients and physicians are looking for targeted comparative effectiveness data as they make treatment decisions. While working with these stakeholders is not new for most companies, these relationships continue to grow in importance. Comparative effectiveness […]

Read More »

Streptococcus Vaccine Clinical Trial to Begin

SASKATOON, Saskatchewan–(BUSINESS WIRE)–The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercialization and Research (CECR) located at the University of Saskatchewan, and Vaxent in Memphis, Tennessee, are pleased to announce the initiation of a Phase 1 clinical trial of StreptAnova®, a vaccine designed to prevent Group A streptococcal (GAS) infections. The trial […]

Read More »

Temple University Health System and GE Healthcare Sign Innovative Value-Based Radiology Services Collaboration Agreement

PHILADELPHIA–(BUSINESS WIRE)–Academic medical centers across the U.S. are experiencing increasing pressure to enhance value – deliver higher quality at lower cost – as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency […]

Read More »

Sales Compensation is a Key Growth Driver for Medical Device Companies

EVANSTON, Ill., Aug. 25, 2015 /PRNewswire/ — Leading medical equipment companies are turning to incentive schemes to accelerate their growth, according to the 2015 Incentive Practices Research study for the medical products industry published this week by ZS Associates. Informed by better use of data, companies are able to make bold moves, motivating sales teams by […]

Read More »

Acorda Therapeutics Shares Surge

A U.S. patent review board on Monday declined to review petitions brought by hedge-fund manager Kyle Bass, who has sought to employ an unusual trading strategy of challenging patents held by pharmaceutical companies and profiting from declines in their stock prices. The U.S. Patent and Trademark Office’s review board ruled against Mr. Bass’s challenge of […]

Read More »

China’s Hepalink USA to Buy American Firm Cytovance for $205.68M+

Hepalink USA, the wholly owned U.S. subsidiary of Shenzhen Hepalink Pharmaceutical, will acquire the biopharmaceutical contract development manufacturing organization Cytovance® Biologics for $205.68 million cash plus additional contingent payments, Cytovance said today. The deal adds a CDMO to Hepalink’s U.S. portfolio, which includes Scientific Protein Laboratories (SPL), a global supplier of active pharmaceutical ingredients (APIs). […]

Read More »

Royal DSM to Slash as Many as 1,100 Jobs to Placate Investors

THE HAGUE, Netherlands (AP) — Dutch nutritional supplements and chemicals company Royal DSM NV says it is laying off between 900 and 1,100 staff worldwide as part of a reorganization of its businesses. The company announced the job cuts Tuesday, saying the move would cut costs by 125-150 million euros ($144-173 million) by the end […]

Read More »

Amgen Opens Up $300 Million Facility in Ireland

Biopharmaceutical giant Amgen has opened its new €300m facility in Dun Laoghaire, following a five-year revamp job of the old Pfizer building. The development included the construction of an 11,500sqm production plant and a 5,800sqm cold chain warehouse – there was also significant refurbishment on buildings that already existed onsite, with total employment numbers there […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom